Jeanne Dumas

Title: Jeanne Dumas: Innovator in Pharmaceutical Composition

Introduction

Jeanne Dumas is a notable inventor based in Bordeaux, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release compositions. With a total of 2 patents, her work has the potential to enhance drug delivery systems.

Latest Patents

One of her latest patents is titled "Controlled release pharmaceutical composition." This invention provides a solid, controlled release pharmaceutical composition that offers enhanced levels of control over drug release. The composition includes an acid addition salt or a quaternary ammonium salt of an organic base drug complexed with an anionic surfactant, all distributed in a matrix of a hydrophilic polymer. The complex formation between the drug and the surfactant results in a composition with excellent controlled release characteristics.

Another significant patent is "Method of producing slow-release pharmaceutical forms." This invention relates to a novel method for producing slow-release pharmaceutical forms administered orally. It employs two resins with anionic character, allowing for variable proportions. By adjusting the ratio of active principles on the respective resins, the release kinetics can be modified, leading to stable pharmaceutical preparations in liquid, semi-liquid, or solid form.

Career Highlights

Jeanne Dumas has worked with reputable companies such as Euro-Celtique S.A. and Société Cortial S.A. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Throughout her career, Jeanne has collaborated with notable coworkers, including Rosa Martani and Elisabeth Le Huede. These collaborations have likely enriched her work and expanded her impact in the pharmaceutical field.

Conclusion

Jeanne Dumas is a pioneering inventor whose work in controlled release pharmaceutical compositions is shaping the future of drug delivery. Her patents reflect her commitment to innovation and improvement in the pharmaceutical industry.